CareCloud Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.0600 |
| EPS actual | $0.0500 |
| EPS Surprise | -16.67% |
| Revenue estimate | 30.506M |
| Revenue actual | 31.27M |
| Revenue Surprise | 2.50% |
| Release date | Mar 12, 2026 |
| EPS estimate | $0.110 |
| EPS actual | $0.110 |
| Revenue estimate | 32.091M |
| Revenue actual | 34.423M |
| Revenue Surprise | 7.27% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.0800 |
| EPS actual | $0.100 |
| EPS Surprise | 25.00% |
| Revenue estimate | 32.099M |
| Revenue actual | 31.067M |
| Revenue Surprise | -3.22% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0700 |
| EPS Surprise | -12.50% |
| Revenue estimate | 29.008M |
| Revenue actual | 27.377M |
| Revenue Surprise | -5.62% |
Last 4 Quarters for CareCloud
Below you can see how CCLD performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $2.38 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0700 |
| EPS surprise | -12.50% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $2.36 |
| Jul 31, 2025 | $2.38 |
| Aug 01, 2025 | $2.31 |
| Aug 04, 2025 | $2.38 |
| Aug 05, 2025 | $2.38 |
| Aug 06, 2025 | $2.55 |
| Aug 07, 2025 | $2.47 |
| Aug 08, 2025 | $2.68 |
| Aug 11, 2025 | $2.56 |
| 4 days before | 0.85% |
| 4 days after | 7.56% |
| On release day | 7.14% |
| Change in period | 8.47% |
| Release date | Nov 06, 2025 |
| Price on release | $3.47 |
| EPS estimate | $0.0800 |
| EPS actual | $0.100 |
| EPS surprise | 25.00% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $2.95 |
| Nov 03, 2025 | $3.01 |
| Nov 04, 2025 | $2.88 |
| Nov 05, 2025 | $2.95 |
| Nov 06, 2025 | $3.47 |
| Nov 07, 2025 | $3.47 |
| Nov 10, 2025 | $3.37 |
| Nov 11, 2025 | $3.31 |
| Nov 12, 2025 | $3.21 |
| 4 days before | 17.63% |
| 4 days after | -7.64% |
| On release day | -0.144% |
| Change in period | 8.64% |
| Release date | Mar 12, 2026 |
| Price on release | $2.91 |
| EPS estimate | $0.110 |
| EPS actual | $0.110 |
| Date | Price |
|---|---|
| Mar 06, 2026 | $2.74 |
| Mar 09, 2026 | $2.73 |
| Mar 10, 2026 | $2.69 |
| Mar 11, 2026 | $2.66 |
| Mar 12, 2026 | $2.91 |
| Mar 13, 2026 | $3.14 |
| Mar 16, 2026 | $3.34 |
| Mar 17, 2026 | $3.61 |
| Mar 18, 2026 | $3.57 |
| 4 days before | 6.20% |
| 4 days after | 22.68% |
| On release day | 7.90% |
| Change in period | 30.29% |
| Release date | May 07, 2026 |
| Price on release | $2.49 |
| EPS estimate | $0.0600 |
| EPS actual | $0.0500 |
| EPS surprise | -16.67% |
| Date | Price |
|---|---|
| May 01, 2026 | $2.99 |
| May 04, 2026 | $2.91 |
| May 05, 2026 | $2.93 |
| May 06, 2026 | $2.99 |
| May 07, 2026 | $2.49 |
| May 08, 2026 | $2.36 |
| May 11, 2026 | $2.25 |
| May 12, 2026 | $2.24 |
| May 13, 2026 | $2.12 |
| 4 days before | -16.89% |
| 4 days after | -14.69% |
| On release day | -5.03% |
| Change in period | -29.10% |
CareCloud Earnings Call Transcript Summary of Q1 2026
CareCloud reported a strong start to 2026 with Q1 revenue of $31.3M, up 13% year-over-year, positive GAAP net income ($0.9M) and $2.4M in free cash flow. Management reaffirmed full-year guidance: revenue $128M–$132M, adjusted EBITDA $29M–$31M and GAAP EPS $0.20–$0.23. The company highlighted progress integrating 2025 acquisitions (notably Medsphere), expanded addressable markets (inpatient/hospital via Wellsoft, CareView, ChartLogic, etc.), and cross-sell opportunities between RCM, benchmarking (MAP App) and AI products. A major corporate finance move in April closed a $50M credit facility and an ATM equity program, and the board is redeeming all Series B preferred shares (reducing preferred overhang, prefunded with facility cash), which management says simplifies the capital structure with no common-share dilution from the redemption itself. Product-wise, CareCloud emphasized its commercialization of AI: stratusAI Desk Agent (handling ~75% of inbound calls at early adopters), cirrusAI Notes (ambient clinical documentation), AI-driven back-office automation for RCM, and additional AI products in development (AI prior authorization, AI-assisted coding). Management expects AI to drive margin gains (through internal automation), retention/expansion (embedded AI in existing products), and new revenue (stand-alone AI products), with integration and amortization of acquisition intangibles impacting near-term GAAP comparatives but expected to improve margins as integration completes.
Sign In
Buy CCLD